|
CDC14A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.403300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.553600E-04 |
| Normal-vs-Stage2 |
1.222040E-01 |
| Normal-vs-Stage3 |
3.928400E-01 |
| Normal-vs-Stage4 |
7.725000E-01 |
| Stage1-vs-Stage2 |
7.378600E-01 |
| Stage1-vs-Stage3 |
4.683900E-02 |
| Stage1-vs-Stage4 |
1.899360E-03 |
| Stage2-vs-Stage3 |
3.046400E-01 |
| Stage2-vs-Stage4 |
1.008960E-01 |
| Stage3-vs-Stage4 |
3.113800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.000600E-03 |
| Normal-vs-AfricanAmerican |
2.203000E-01 |
| Normal-vs-Asian |
2.075800E-01 |
| Caucasian-vs-AfricanAmerican |
9.802000E-01 |
| Caucasian-vs-Asian |
7.655200E-01 |
| AfricanAmerican-vs-Asian |
8.346800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.576600E-01 |
| Normal-vs-Female |
1.019010E-03 |
| Male-vs-Female |
2.956700E-03 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.410600E-04 |
| Normal-vs-Age(41-60Yrs) |
3.777800E-02 |
| Normal-vs-Age(61-80Yrs) |
4.596400E-01 |
| Normal-vs-Age(81-100Yrs) |
7.709700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.404400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.819800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.781030E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.311600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.697500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.991900E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.57840000034749E-07 |
| Classical-VS-Follicular |
4.760300E-03 |
| Classical-VS-Other |
6.702000E-01 |
| Classical-VS-Normal |
1.354560E-04 |
| Tall-VS-Follicular |
1.644550E-01 |
| Tall-VS-Other |
3.503600E-01 |
| Tall-VS-Normal |
2.021400E-01 |
| Follicular-VS-Other |
6.054000E-01 |
| Follicular-VS-Normal |
7.938600E-01 |
| Other-VS-Normal |
5.713200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.049500E-02 |
| Normal-vs-N1 |
6.493400E-01 |
| N0-vs-N1 |
1.435760E-01 |
|
|
